Enzolite-Plus Tablet is a combination pharmaceutical formulation containing Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg, and Diclofenac 50 mg, designed to provide effective anti-inflammatory, analgesic, and proteolytic enzyme therapy. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins and promote the resolution of inflammation and edema by enhancing fibrinolytic activity and reducing inflammatory mediators. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, thereby reducing capillary permeability and fragility, which aids in minimizing bruising and swelling. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins responsible for pain, inflammation, and fever. The synergistic action of these components makes Enzolite-Plus effective in managing acute and chronic inflammatory conditions such as musculoskeletal injuries, postoperative edema, soft tissue inflammation, and joint disorders. It is indicated for relief of pain and inflammation associated with sprains, strains, contusions, and arthritis. Enzolite-Plus should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, bleeding disorders, or gastrointestinal ulcers. Adherence to prescribed dosage and monitoring for adverse effects is essential to ensure therapeutic efficacy and safety.